Leap Therapeutics has been renamed Cypherpunk and acquired 203,800 ZEC reserves.

Nasdaq-listed biotech company Leap Therapeutics announced its name change to Cypherpunk Technologies Inc. and the completion of a private funding round of approximately $58.88 million, fully led by Winklevoss Capital. The company has used $50 million to purchase 203,775.27 ZEC tokens at an average price of $245; the remaining funds will be used to advance its parallel strategy of digital assets and biotech. The company adopted the new ticker symbol CYPH on Thursday. Management changes include Khing Oei as Chairman and Will McEvoy as CEO, joining the board of directors.